These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 812575)
1. Hyperlipidemia, hypercoagulability, and accelerated thrombosis: studies in congenitally hyperlipidemic rats and in rats and monkeys with induced hyperlipidemia. Kim WM; Merskey C; Deming QB; Adel HN; Wolinsky H; Clarkson TB; Lofland HB Blood; 1976 Feb; 47(2):275-86. PubMed ID: 812575 [TBL] [Abstract][Full Text] [Related]
2. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation. De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312 [TBL] [Abstract][Full Text] [Related]
3. Clotting mechanisms in patients with hypertriglyceridemia during therapy with anabolic or progestational drugs. Glueck HI; Glueck CJ Thromb Diath Haemorrh; 1973 May; 29(2):499-509. PubMed ID: 4762263 [No Abstract] [Full Text] [Related]
4. A true hypercoagulability state in patients on chronic hemodialysis. Erickson RV; Williman M; Pendras JP Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704 [No Abstract] [Full Text] [Related]
6. Blood-clotting mechanisms of nonhuman primates. Choice of the baboon model to simulate man. Todd ME; McDevitt E; Goldsmith EI J Med Primatol; 1972; 1(3):132-41. PubMed ID: 4633128 [No Abstract] [Full Text] [Related]
7. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels. Constantino M; Merskey C; Kudzma DJ; Zucker MB Thromb Haemost; 1977 Aug; 38(2):465-74. PubMed ID: 579489 [TBL] [Abstract][Full Text] [Related]
8. Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III. Chirnside A; Urbaniak SJ; Prowse CV; Keller AJ Br J Haematol; 1981 Aug; 48(4):627-34. PubMed ID: 6791676 [TBL] [Abstract][Full Text] [Related]
9. [Experimental studies of hyperlipidemia in rats and mice given a hyperlipidemic diet]. Yang SY; Bao JH; Zhang JP Zhongguo Zhong Yao Za Zhi; 1989 Jan; 14(1):48-51, 64. PubMed ID: 2504194 [TBL] [Abstract][Full Text] [Related]
10. Feeding of butylated hydroxytoluene to rats caused a rapid decrease in blood coagulation factors II (prothrombin), VII, IX and X. Takahashi O Arch Toxicol; 1986 Feb; 58(3):177-81. PubMed ID: 3964081 [TBL] [Abstract][Full Text] [Related]
11. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life]. Duvina PL; Simoni MR; Pezzati M; Poggi G; Rosati C; Trampi F; Duvina G Minerva Pediatr; 1987 May; 39(10):421-36. PubMed ID: 3116376 [No Abstract] [Full Text] [Related]
12. The influence of ethanol feeding on the activities of factors II, VII, VIII, IX and X in rats. Morland J; Holm T; Prydz H Thromb Haemost; 1976 Dec; 36(3):532-6. PubMed ID: 1037150 [TBL] [Abstract][Full Text] [Related]
13. Blood coagulation changes in rats during development of epithelioma. Tomasiuk R; Gawlowska H; Sawicka B; Mielicki W; Wierzbicki R Neoplasma; 1989; 36(2):179-84. PubMed ID: 2716922 [TBL] [Abstract][Full Text] [Related]
14. Normal levels of fibrinopeptide A in patients with primary hyperlipidemia. Nossel HL; Smith FR; Seplowitz AH; Dell RB; Sciacca RR; Merskey C; Goodman DS Circ Res; 1979 Sep; 45(3):347-50. PubMed ID: 455600 [TBL] [Abstract][Full Text] [Related]
15. Studies on hypo- and hypercoagulability. II. Coagulation and fibrin analyses in severe infectious and toxic conditions. Kunz F; Hörtnagl H; Kroesen G; Schennach W; Egg D; Rumpl E; Aschauer R; Holzknecht F Blut; 1974 May; 28(5):360-9. PubMed ID: 4421162 [No Abstract] [Full Text] [Related]
16. Coagulation in cephalhaematomas. Ströder J; Mingers AM Z Kinderheilkd; 1974; 116(4):153-61. PubMed ID: 4825915 [No Abstract] [Full Text] [Related]
17. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. Odegard KC; McGowan FX; Zurakowski D; Dinardo JA; Castro RA; del Nido PJ; Laussen PC J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1260-7. PubMed ID: 12830042 [TBL] [Abstract][Full Text] [Related]